Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection - New York and Georgia, 2000

JAMA

Volumn 285, Issue 20, 2001, Pages 2572-2573

  DeMartino, M ^a   Maniscalco, J ^b   Greenberg, A ^b   Grabau, J ^c   Oxtoby, M ^c   Foster, E ^c   Smith, P ^d   Kozarsky, P ^e   Pox, C ^e  

^a Nassau County Office of the Medical Examiner   (Bahamas)

^b Nassau County Department of Health   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANOREXIA; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; FEMALE; FEVER; HEPATITIS; HUMAN; JAUNDICE; LASSITUDE; LIVER NECROSIS; LIVER TOXICITY; LUNG TUBERCULOSIS; MALAISE; MALE; PRIORITY JOURNAL; SHORT SURVEY; SYMPTOM; UNITED STATES; ARTICLE; DRUG COMBINATION; FATALITY; MIDDLE AGED; TOXIC HEPATITIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; GEORGIA; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; NEW YORK; PYRAZINAMIDE; RIFAMPIN; TUBERCULOSIS;

EID: 0035938696     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.20.2572     Document Type: Short Survey

References (0)